Eli Lilly and JDRF to fund research into beta cell regeneration
Eli Lilly and Company (NYSE: LLY) and the Juvenile Diabetes Research Foundation (JDRF) announced in early February 2011 that they have signed an agreement to
Eli Lilly and Company (NYSE: LLY) and the Juvenile Diabetes Research Foundation (JDRF) announced in early February 2011 that they have signed an agreement to
Researchers say that a common cold virus may be responsible for triggering Type 1 diabetes in children already at risk for the disease, according to
New research has shown that the artificial pancreas can keep blood sugar levels normal overnight for pregnant women. Diabetes poses a particular challenge for pregnant
A study has been undertaken whereby HbA1c changes over more than 3 years were evaluated in type 1 diabetic patients who were younger than 18 years and
Drugmaker Merck is buying privately held company SmartCells, which is developing an experimental form of “intelligent insulin,” according to a recent article from the Financial
Because of evidence that beta-cell failure occurs earlier and more severely in patients with type 2 diabetes, a new consensus statement suggests that greater emphasis
As reported by DRWF UK, newly published research by the University of Bristol has shown that a dietary supplement of the synthetic derivative of vitamin
Living Cell Technologies announced that its Diabecell porcine implant for people with Type 1 diabetes as well as xenotransplantation has been approved for use in
Almonds may help improve insulin sensitivity and decrease LDL-Cholesterol levels for people with prediabetes, a condition that often leads to Type 2 diabetes, according to
Diamyd is forging ahead with a Phase III human trial of DiaPrevent, a potentially new treatment that can stop or slow the destruction of insulin-producing